RETROPERITONEAL SARCOMA

This study is testing a new, targeted form of proton radiation therapy for people newly diagnosed with a rare abdominal cancer called retroperitoneal sarcoma. The goal is to see if this new technique, which aims to deliver higher radiation doses directly to the tumor while sparin…

This study is testing a new approach for a rare abdominal cancer called retroperitoneal sarcoma. Doctors want to see if giving a few very high doses of targeted radiation before surgery is safe and helps control the tumor. The study will enroll 50 patients to check for complicati…

This early-phase trial is testing whether a shorter, more intense course of radiation is safe for people with retroperitoneal sarcoma, a rare cancer in the abdomen. The study will enroll 6 adults to monitor side effects like nausea and diarrhea in the first month after treatment.…

This early-stage study is testing whether adding a drug called abemaciclib to standard radiation therapy before surgery is safe and can help shrink tumors in patients with high-risk abdominal sarcomas. The trial will enroll 18 adults with this rare cancer to find the best dose an…

This study is testing whether a more targeted form of radiation (using protons or advanced photons) given before surgery can better control rare abdominal tumors called retroperitoneal sarcomas. Researchers want to find the safest, most effective dose and see if this approach red…

This study aims to understand how personalized chemotherapy before surgery works for high-risk sarcoma patients. Researchers will collect tissue samples from 800 patients who either receive chemotherapy before surgery or go directly to surgery. By analyzing these samples, they ho…

This study aims to understand how different surgical techniques for removing complex abdominal tumors affect patients' recovery and quality of life. It will observe 120 patients who have had major surgery for retroperitoneal sarcoma, tracking complications and bowel function. The…